Patients with high-risk atrial fibrillation, or AFib , often require one drug to regulate heart rhythm and a second drug to thin their blood and reduce the risk of stroke. A study led by a University of Missouri School of Medicine cardiologist and published in March 2015 in the Journal of the American College of Cardiology , a publication of the American College of Cardiology Foundation, found that use of a newer blood thinner significantly decreased the risk of strokes for patients with AFib who require both types of medication. A release from the university notes that although the anticoagulant warfarin has been the standard of care since the 1940s , more recent advancements in blood-thinning medication led to the development of the drug apixaban .
Follow this link:
Safer Drug Combo for AFib